V

Vega Health

Curated clinical AI marketplace and platform

Overview

Vega Health builds a platform that helps health systems adopt and scale artificial intelligence. It runs a curated marketplace of AI models that have been vetted for safety and effectiveness in real clinical settings. For clients, Vega provides a platform to test models against local patient data (like electronic health records) to ensure the model will work with their population before purchase, plus implementation support and ongoing, objective monitoring of technical performance, clinician adoption, and patient outcomes. For AI developers, Vega offers a channel to commercialize and distribute models to a broader market. Revenue comes from a revenue-sharing arrangement with the AI model owners after a health system makes a purchase. The company aims to bridge the gap between AI creators and health systems, validating models locally, and providing a scalable path for responsible AI adoption that improves clinician workflows and patient care.

Work here?Claim your company

About Vega Health

Simplify's Rating
Why Vega Health is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareAI & Machine LearningHealthcare

Company Size

11-50

Company Stage

Seed

Total Funding

$4M

Headquarters

Durham, NC

Founded

2025

Get referred to Vega Health

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • PCCI licensed five clinically validated models to Vega in June 2026.
  • Elion listed Baptist Health Jacksonville as a verified customer in July 2026.
  • Utah’s AI sandbox role creates a visible reference customer and regulatory credibility.

What critics are saying

  • Vega reported only two live community health system customers in June 2026.
  • Revenue-share dependence on Duke and PCCI concentrates supply and bargaining power.
  • If hospitals bypass the marketplace and buy direct, Vega’s commercialization layer collapses.

What makes Vega Health unique

  • Mark Sendak’s Duke and HAIP history gives Vega deep clinical trust credentials.
  • Vega validates AI on local patient data before deployment, not generic benchmarks.
  • Utah’s October 2026 sandbox chose Vega as independent evaluator for healthcare AI.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$4M

Above

Industry Average

Funded Over

1 Rounds

Notable Investors:
Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
$2.3M
$3M
$4M

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Company Equity
  • Pet Insurance
  • Paid Vacation
  • Paid Sick Leave
  • Parental Leave

Company News

The Infotech
Oct 6th, 2026
Vega Health selected as evaluator for Utah AI sandbox.

Vega Health selected as evaluator for Utah AI sandbox. ET By Editorial Team October 6, 2026 Vega Health has been selected as an independent, third-party evaluator for the Utah Office of AI Policy's AI Regulatory Sandbox. Through the sandbox, the Office of AI Policy has created the opportunity to expand access to and safely test emerging AI technologies that can improve outcomes for populations and communities across Utah. By working with objective, third-party evaluators like Vega Health, the Office of AI Policy will be able to make data-backed decisions about which vendors to include in its AI sandbox. Furthermore, enabling this layer of objective and independent evaluations will improve public trust in the AI technologies that are deployed while increasing the safety of each implementation. As a Trusted Third-Party Evaluator, Vega Health will: * Provide infrastructure to safely and securely test AI model performance before deployment; * Benchmark AI models across historical or real-time patient encounters at Vega Health partner sites to simulate how the model might perform during a pilot rollout; * Validate technical claims made by applicants with real-world performance data; * Audit the accuracy of AI decisions; and * Share the real-world independent evaluation of models with applicants and the OAIP. The results of each independent evaluation will be shared back to the state to help inform sandbox participation and guardrails. Vega Health will also provide results back to the applicant to enable product improvements. "Third-party evaluation of AI is important so that users of the technology don't have to rely solely on vendor performance claims," said Mark Sendak, CEO and Co-Founder of Vega Health. "Utah's health systems and patients deserve to know that AI tools being piloted under regulatory relief are accurate, safe, and validated before deployment. Vega Health is well positioned for this role because we have experience conducting independent model evaluations and generating evidence in support of health systems and their priorities. We are grateful to the Office of AI Policy for selecting us for this important role in the oversight of the nation's first AI sandbox for healthcare."

Associated Press
Jun 10th, 2026
Vega Health partners with PCCI to scale AI models for vulnerable populations nationwide

Vega Health has announced a licensing agreement with Parkland Center for Clinical Innovation (PCCI), making five clinically validated AI models available on its marketplace. The models were developed at Parkland Health, a Dallas County safety-net health system serving diverse and underserved populations. The models address critical clinical challenges including sepsis prediction, trauma mortality risk assessment, adverse drug event prevention and workplace safety screening. PCCI's inpatient sepsis model fires 19 hours before typical antibiotic administration, compared to 1.5 hours for current industry models. The partnership aims to scale AI solutions developed within health systems to other healthcare organisations. PCCI has spent over a decade developing and monitoring AI in complex clinical environments, generating nearly 35 million predictions over six years. Health systems can evaluate models on local data before implementation, with Vega Health supporting clinical adoption and monitoring.

Fenoms Talent
Oct 21st, 2025
Vega Health Raises $4 Million in Seed Funding to Build the Future of AI-Driven Clinical Intelligence

Vega Health raises $4 million in Seed funding to build the future of ai-driven clinical intelligence. Vega Health, an emerging healthcare technology company co-founded by Mark Sendak, MD, MPP, has raised $4 million in Seed funding led by Bessemer Venture Partners. The funding marks a major milestone in Vega's mission to transform how hospitals and health systems harness AI for clinical decision-making and operational excellence. By combining data science with clinical expertise, Vega Health is building a next-generation platform that helps care teams move from reactive decisions to proactive, data-informed interventions, bridging the long-standing gap between analytics and clinical practice. Reimagining clinical decision intelligence. Modern healthcare is overwhelmed with data but starved for actionable insight. Clinicians are inundated with electronic health records (EHRs), lab reports, and patient histories - yet most systems fail to synthesize that data into meaningful recommendations at the point of care. Vega Health aims to change that. Its platform uses AI and predictive modeling to surface clinically relevant insights directly into existing workflows. The result: faster decisions, fewer errors, and a measurable improvement in patient outcomes. "We're giving clinicians the intelligence they need to act faster and smarter," said Dr. Mark Sendak, CEO and Co-Founder. "Healthcare generates vast amounts of data, but it's often trapped in silos. Vega bridges that gap - translating complexity into clarity." Unlike legacy analytics dashboards, Vega's technology integrates seamlessly into hospital systems, presenting insights in real-time and in context. This approach allows care teams to focus on patients, not spreadsheets. Building bridges between data and doctors. Dr. Sendak's experience as both a physician and data scientist is central to Vega Health's philosophy. Before founding Vega, he spent years witnessing how poor data integration and cognitive overload limited clinical performance. His takeaway was simple: AI won't replace clinicians - it should empower them. Vega's platform embodies this belief. Rather than imposing new systems, it works within existing EHR frameworks, applying machine learning to highlight the most critical patient data. From identifying early signs of sepsis to optimizing discharge planning, Vega Health's AI models are designed to reduce burnout, improve accuracy, and streamline care coordination. By doing so, Vega bridges one of the biggest divides in healthcare - the communication gap between clinical intuition and computational intelligence. A deep insight for founders: the Clinical Trust Flywheel. One of Vega Health's smartest moves is its focus on clinical trust - a concept many AI healthcare startups underestimate. In an industry where decisions impact lives, adoption depends less on cutting-edge models and more on earned credibility. Vega has built its product around the principle of transparency: every AI recommendation can be traced, validated, and explained. This transparency fuels what can be called the Clinical Trust Flywheel: * Clinicians understand how the system makes recommendations. * They trust and use it more often. * The system collects richer data and improves faster. * Improved performance drives even greater trust and adoption. For founders in healthcare AI, Vega's approach offers a crucial lesson: trust isn't a feature - it's the foundation. Without it, even the most powerful AI tools will fail to scale in clinical environments. The role of Bessemer Venture Partners. Backing from Bessemer Venture Partners signals strong conviction in Vega's vision and technical roadmap. As one of the most respected venture firms in healthcare and enterprise software, Bessemer brings not only capital but also strategic guidance in scaling healthtech products across regulated markets. The partnership will allow Vega Health to accelerate product development, expand partnerships with hospital networks, and deepen its AI research initiatives focused on predictive care and operational resilience. "Vega Health is tackling one of the biggest pain points in modern medicine - how to turn massive amounts of healthcare data into meaningful, real-time insights," said a spokesperson from Bessemer Venture Partners. "Their physician-led approach is what sets them apart." Market outlook: the ai-enabled healthcare revolution. The AI in healthcare market is projected to surpass $200 billion by 2030, growing at a CAGR of 37% (Allied Market Research, 2024). Hospitals are under increasing pressure to reduce costs, improve efficiency, and deliver consistent outcomes - challenges that require intelligent automation and predictive systems. However, despite AI's promise, adoption remains limited by workflow friction and data fragmentation. Vega Health's embedded design philosophy - integrating intelligence directly into clinical systems rather than layering it on top - addresses precisely these barriers. Moreover, with physician burnout at record highs and nearly 47% of clinicians reporting decision fatigue (AMA, 2025), the demand for tools that simplify rather than complicate is skyrocketing. Vega's promise to humanize AI for healthcare positions it squarely at this intersection of need and innovation. What's next for Vega Health. With its $4 million Seed round, Vega Health plans to: * Expand its AI engineering and clinical informatics teams. * Develop deeper EHR integrations with leading hospital systems. * Pilot predictive care models across major U.S. healthcare networks. * Strengthen partnerships with academic medical centers to validate clinical outcomes. The company also plans to invest in regulatory readiness and interoperability standards, ensuring its platform meets the stringent compliance demands of healthcare environments. Final thoughts. Vega Health's Seed funding marks a critical moment in the evolution of clinical intelligence. By blending physician insight with advanced AI, Vega is turning healthcare's most overwhelming problem - too much data - into its greatest asset. The company's mission transcends automation; it's about amplifying human judgment through technology that's trustworthy, explainable, and deeply aligned with patient care. As healthcare systems race toward AI transformation, Vega Health stands out not just for what it builds, but for how it builds - with empathy, precision, and purpose. Growth & scaling insights. Latest additions.

Recently Posted Jobs

Sign up to get curated job recommendations

Vega Health is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs